Liu, Y.; Cui, R.; Wang, Z.; Lin, Q.; Tang, W.; Zhang, B.; Li, G.; Wang, Z.
Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging. Pharmaceuticals 2024, 17, 373.
https://doi.org/10.3390/ph17030373
AMA Style
Liu Y, Cui R, Wang Z, Lin Q, Tang W, Zhang B, Li G, Wang Z.
Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging. Pharmaceuticals. 2024; 17(3):373.
https://doi.org/10.3390/ph17030373
Chicago/Turabian Style
Liu, Yifan, Ruizhe Cui, Zhixiong Wang, Qi Lin, Wei Tang, Bing Zhang, Guanghua Li, and Zhao Wang.
2024. "Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging" Pharmaceuticals 17, no. 3: 373.
https://doi.org/10.3390/ph17030373
APA Style
Liu, Y., Cui, R., Wang, Z., Lin, Q., Tang, W., Zhang, B., Li, G., & Wang, Z.
(2024). Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging. Pharmaceuticals, 17(3), 373.
https://doi.org/10.3390/ph17030373
